Worldwide Medical Enzyme Technology Industry to 2028 - by Enzyme Type, Application and Geography

Dublin, IRELAND


Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Medical Enzyme Technology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type; Application, and Geography" report has been added to ResearchAndMarkets.com's offering.

The global medical enzyme technology market is expected to reach US$ 6,700.00 million by 2028 from US$ 4,012.57 million in 2020; it is estimated to grow at a CAGR of 6.7% during 2021-2028.

Enzymes play a crucial role in the metabolic activities of all organisms. They have an extensive range of applications in microbial biotechnology and diagnosis processes. Abnormalities in enzyme metabolism system leads to many metabolic diseases. Many enzymes are being widely used in the clinical examination as a specific disease marker. Further, medicinal enzymes can be used as medicines to treat a range of diseases. They are characterized by remarkable curative effect and insignificant side effects. For example, trypsin can be used to accelerate wound healing, dissolve blood clots, remove necrotic tissue, and inhibit contaminant growth (in cell cultures). L-asparaginase can be used to treat cancer by depriving nutrients needed for the growth of cancer cells. Protease (provide in the form of multi-enzyme tablets) can be used to treat dyspepsia; many proteases have anti-inflammatory properties.

Moreover, lipase, superoxide dismutase, nattokinase, soybean meal plasmin, and thrombin, among others, can be used to treat various diseases. Enzymes are the preferred markers in various disease states such as myocardial infarction, jaundice, pancreatitis, cancer, and neurodegenerative disorders. They assist in diagnosis, prognosis, and assessment of response therapy. Furthermore, many enzymes are used as diagnostic reagents. Due to the unique enzyme characteristics of specificity, high-catalytic efficiency, and mild action conditions, the enzymatic diagnosis has become a reliable, simple, and rapid method.

The medical enzyme technology market, by enzyme type, is segmented into digestive enzymes, thrombolytic enzymes, hydrolases, and endonucleases. The hydrolases segment held the largest share of the market in 2020; however, the thrombolytic enzymes segment is anticipated to register the highest CAGR of 7.2% during the forecast period.

In terms of technique, the medical enzyme technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held a larger market share in 2019. However, the market for normothermic machine perfusion is estimated to grow at a higher CAGR of 4.4% during the forecast period.

The medical enzyme technology market, by application, is segmented into disease treatment, diagnostic tools, biomedical research, and others. The disease treatment segment held the largest share of the market in 2020, and the same segment is anticipated to register the highest CAGR of 7.1% in the market during the forecast period.

The Central Drugs Standard Control Organization, Commission for Protection against Health Risks, Contract Research Organizations, and Drug Safety and Effectiveness Network are among the major secondary sources referred to while preparing the report on the medical enzyme technology market.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical enzyme technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global medical enzyme technology market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Medical Enzyme Technology Market - By Enzyme Type
1.3.2 Global Medical Enzyme Technology Market - By Application
1.3.3 Global Medical Enzyme Technology Market - By Geography

2. Medical Enzyme Technology Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Medical Enzyme Technology Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion

5. Medical Enzyme Technology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Applications of Enzymes in Diagnosis and Disease Treatment
5.1.2 Significant Increase in Research and Development Activities
5.2 Market Restraints
5.2.1 Handling and Safety Issues Related to Enzymes
5.3 Market Opportunities
5.3.1 Rising Production of Biopharmaceutical Products
5.4 Future Trends
5.4.1 Advancements in Enzyme Engineering
5.5 Impact Analysis of Drivers and Restraints

6. Medical Enzyme Technology Market - Global Analysis
6.1 Global Medical Enzyme Technology Market Revenue Forecast and Analysis
6.2 Global Medical Enzyme Technology Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Medical Enzyme Technology Market Analysis - By Enzyme Type
7.1 Overview
7.2 Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020-2028)
7.3 Digestive Enzymes
7.3.1 Overview
7.3.2 Digestive Enzymes: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 L-asparaginase Market
7.3.3.1 Overview
7.3.3.2 L-asparaginase: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Lactase Market
7.3.4.1 Overview
7.3.4.2 Lactase: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Others Market
7.3.5.1 Overview
7.3.5.2 Others: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Thrombolytic Enzymes
7.4.1 Overview
7.4.2 Thrombolytic Enzymes: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Streptokinase Market
7.4.3.1 Overview
7.4.3.2 Streptokinase: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Urokinase Market
7.4.4.1 Overview
7.4.4.2 Urokinase: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Others Market
7.4.5.1 Overview
7.4.5.2 Others: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Hydrolases Enzymes
7.5.1 Overview
7.5.2 Hydrolases: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5.3 Hyaluronidase Market
7.5.3.1 Overview
7.5.3.2 Hyaluronidase: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5.4 Lysozymes Market
7.5.4.1 Overview
7.5.4.2 Lysozymes: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others Market
7.5.5.1 Overview
7.5.5.2 Others: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Endonucleases
7.6.1 Overview
7.6.2 Endonucleases: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6.3 Benzonase
7.6.3.1 Overview
7.6.3.2 Benzonase: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6.4 Others
7.6.4.1 Overview
7.6.4.2 Others: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Medical Enzyme Technology Market Analysis - By Application
8.1 Overview
8.2 Medical Enzyme Technology Market Revenue Share, by Application (2020-2028)
8.3 Disease Treatment
8.3.1 Overview
8.3.2 Disease Treatment: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Tools
8.4.1 Overview
8.4.2 Diagnostic Tools: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Biomedical Research
8.5.1 Overview
8.5.2 Biomedical Research: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Medical Enzyme Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Medical Enzyme Technology Market - Geographical Analysis
9.1 North America
9.2 Europe: Medical Enzyme Technology Market
9.3 Asia Pacific
9.4 South and Central America: Medical Enzyme Technology Market
9.5 Middle East and Africa: Medical Enzyme Technology Market

10. Impact Of COVID-19 Pandemic on Global Medical Enzyme Technology Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South & Central America: Impact Assessment of COVID-19 Pandemic

11. Medical Enzyme Technology Market-Industry Landscape
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done by Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Developments Done by Companies

12. Company Profiles
12.1 MERCK KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 THERMO FISHER SCIENTIFIC INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novozymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Takeda Pharmaceutical Company Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Agilent Technologies, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Genzyme Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Promega Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cytiva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amano Enzyme Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/3k7cef

 

Contact Data